PNC Financial Services Group
VRCA icon

PNC Financial Services Group’s Verrica Pharmaceuticals VRCA Stock Holding History

PNC Financial Services Group’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624 Hold
102
– – ﹤0.01% 4936
2026
Q1 		$540 Hold
102
– – ﹤0.01% 4896
2025
Q4 		$847 Hold
102
– – ﹤0.01% 4733
2025
Q3 		$439 Sell
102
-1
-1% -$6 ﹤0.01% 4826
2025
Q2 		$547 Sell
103
-328
-76% -$1.76K ﹤0.01% 4672
2025
Q1 		$1.91K Buy
431
+419
+3,492% +$2.71K ﹤0.01% 4360
2024
Q4 		$81 Sell
12
-35
-74% -$385 ﹤0.01% 4720
2024
Q3 		$677 Buy
47
+25
+114% +$1.13K ﹤0.01% 4522
2024
Q2 		$1.62K Hold
22
– – ﹤0.01% 4310
2024
Q1 		$1.31K Buy
22
+21
+2,100% +$1.16K ﹤0.01% 4305
2023
Q4 		$88 Buy
+1
New +$41 ﹤0.01% 4523

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group's VRCA Position: Q2 2026 in Review

PNC Financial Services Group held its Verrica Pharmaceuticals (VRCA) position steady in Q2 2026 at 102 shares worth $624. The position accounts for ﹤0.01% of the portfolio, ranked #4936.

PNC Financial Services Group first reported a position in VRCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.91K in Q1 2025. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • PNC Financial Services Group held 102 shares of Verrica Pharmaceuticals worth $624 as of Q2 2026.
  • PNC Financial Services Group left its Verrica Pharmaceuticals share count unchanged in Q2 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4936 holding.
  • PNC Financial Services Group first reported a position in Verrica Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • PNC Financial Services Group's Verrica Pharmaceuticals position peaked at $1.91K in Q1 2025.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.